Score associated with the outcome after multiple ablation procedures in patients with atrial fibrillation

Maciej Wójcik1, Alexander Berkowitsch, Sergey Zaltsberg

  • 1Department of Cardiology, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany; Department of Cardiology, Medical University of Lublin, Lublin, Poland.

Insights

Multiple catheter ablation procedures improve atrial fibrillation outcomes, especially in patients with higher ALARMEC scores. Antiarrhythmic drugs further enhance success rates in these complex cases.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Catheter ablation (CA) is a key treatment for atrial fibrillation (AF).
  • Achieving satisfactory outcomes often requires multiple procedures (MPs).
  • Patient risk stratification is crucial for predicting CA success.

Purpose of the Study:

  • To evaluate the effectiveness of multiple catheter ablation procedures (MPs) in treating atrial fibrillation (AF).
  • To assess outcomes based on patient risk stratification using the ALARMEC score.
  • To determine the impact of antiarrhythmic drugs (AADs) on AF ablation success.

Main Methods:

  • A cohort of 911 AF patients undergoing catheter ablation (CAAF) was followed for 60 months.
  • The ALARMEC risk score (Atrial fibrillation type, Left Atrium size, Renal insufficiency, MEtabolic syndrome, cardiomyopathy) was calculated for each patient.
  • Maintenance of sinus rhythm was the primary endpoint.

Main Results:

  • Overall success improved from 56% after the first procedure to 76% with MPs.
  • Higher ALARMEC scores correlated with increased need for MPs and decreased success rates.
  • Patients on AADs showed varied success rates based on ALARMEC score, while those without AADs generally had better outcomes.

Conclusions:

  • Multiple catheter ablation procedures significantly improve AF management outcomes.
  • The ALARMEC score effectively stratifies patients, predicting the need for MPs and guiding treatment intensity.
  • Adjunctive antiarrhythmic drug therapy can further enhance success rates, particularly in higher-risk individuals.
Abstract